Navigation Links
$50 million to speed discoveries for patients
Date:11/12/2012

Washington University School of Medicine in St. Louis has received a $50 million grant to help speed the translation of scientific discoveries into improvements in human health.

The grant, from the National Institutes of Health (NIH), supports the School of Medicine's Institute of Clinical and Translational Sciences (ICTS), one of 60 such centers in the United States.

"We're working to advance clinical and translational research throughout the university," says ICTS Director Bradley A. Evanoff, MD, assistant dean for clinical and translational research. "The ICTS is not built around one specific disease or clinical specialty. We are charged with speeding the application of research findings in prevention, diagnosis and treatment across a wide spectrum of health conditions and research disciplines."

The grant is a renewal of a Clinical and Translational Science Award (CTSA), funded through the new National Center for Advancing Translational Sciences (NCATS), which is a part of the NIH.

Evanoff says the ICTS will support Washington University's strengths and, in doing so, help pursue the goals of the BioMed 21 initiative to encourage cross-disciplinary and translational research. Over the next five years, the ICTS will increasingly focus on promoting three areas likely to have a high impact: translating research in genetics and genomics into patient care; developing and evaluating new therapeutics; and improving ways to disseminate and implement research findings so they become part of regular medical practice.

According to Evanoff, Washington University has tremendous strengths in genetic and genomic research, and is beginning to apply the results of this research to patient care. Working with investigators in the departments of genetics and pathology and immunology, the ICTS established a Genomics Medicine Program to provide easier access to a wide range of new technologies. This is allowing more investigators to apply the tools and techniques of the genetic revolution to improve diagnosis and treatment of a host of conditions.

To speed development and evaluation of new therapeutics, the ICTS will collaborate with Washington University faculty and regional partners including Saint Louis University and the St. Louis College of Pharmacy to develop new drugs, biologics, medical devices and diagnostic tests.

Evanoff and his colleagues note that it sometimes can take years to incorporate research findings into usual medical practice. As such, the ICTS also supports the later stages of translational research most likely to benefit patients quickly. In particular, they will foster a close partnership with BJC HealthCare, the largest non-profit healthcare network in the Midwest.

In general, translational research is divided into four stages:

Taking a discovery made in the lab, often in animal models of disease, and evaluating it in humans for the first time.

Performing early clinical trials looking at safety and effectiveness in highly controlled conditions with a relatively small number of patients.

Conducting larger clinical trials in which the treatment is tested in normal clinical practice with a broader population of patients.

Spreading the word. Once something is known to work, the next step is to encourage its wide adoption across medical practices.

"We are supporting research and education across all stages of this translational research spectrum," Evanoff says. "We serve as a bridge between basic and clinical science, support early-stage clinical research and clinical trials, and link research findings to their applications in medical practice and public health."

Other major goals of the ICTS include providing financial support and training for new investigators in clinical and translational research, building new research support infrastructure, encouraging collaborations among faculty across disciplines, and creating pathways for investigators to find and utilize existing research resources.

"'Democratization of technology is a goal of the ICTS," Evanoff says. "By collaborating with existing resources at Washington University and our regional partners, we've enabled a broader group of investigators to gain access to cutting-edge technologies in imaging, genetics, and other important areas."

Evanoff also emphasizes that the ICTS is a regional consortium that includes important partnerships with BJC HealthCare, Barnes-Jewish Hospital, St. Louis Children's Hospital, Saint Louis University, the St. Louis College of Pharmacy, the Goldfarb School of Nursing, and the nursing schools at the University of Missouri-St. Louis and Southern Illinois University-Edwardsville.

"Together with our regional and national partners, our mission is to connect research findings to their eventual application in improving the health of the public," Evanoff says. "That's the exciting part of translational research."


'/>"/>

Contact: Julia Evangelou Strait
straitj@wustl.edu
314-286-0141
Washington University School of Medicine
Source:Eurekalert

Related medicine news :

1. MU Nursing School receives $14.8 million for project to reduce re-hospitalizations
2. Weill Cornell receives $1.5 million in Grand Challenges Explorations grants
3. RIT receives $3.2 million award from the NSF to advance female faculty
4. Millions Brace as Hurricane Sandy Slams the East Coast
5. Millions Prepare as Hurricane Sandy Starts Assault on East Coast
6. Millions May Be Taking Vitamin D Unnecessarily, Analysis Suggests
7. $3.4 million HHS grant to help UIC address shortage of Latino health providers
8. $20 million gift launches new hub for global health at UCSF
9. $1.8 million grant supports investigation of psoriasis link to cardiovascular disease
10. Systems biologist receives $2.5 million Pioneer Award for genome research
11. Scripps Research Institute receives $20 million to shed light on HIV drug resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of ... “Imagine Me Beyond What You See” body image mannequin art competition. Selected from 15 ... showcased and the winner revealed at the 31st annual iaedp Symposium, March 22 – ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Radiology Business Management Association ... programs at the annual Building Better Radiology Marketing Programs conference, held this ... Fort Worth, Texas. Nine awards are given out in five categories. They are:, ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... into the Senior International Elite division on February 12th. Ms. Esparza qualified ... at the elite qualifier competition held in Las Vegas, Nevada. Frida is one ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning sunscreen ... Fondo of Marin. For the second year in a row, cyclists will stay ... “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling ...
(Date:2/23/2017)... ... , ... The 89th Academy Awards will be celebrated this weekend, which means ... Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek “salute” to the ... Center for American Progress (CAP), for its report, Lessons From State Performance on NAEP: ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Pharma To Market Pty Ltd and Ador Consulting Pte Ltd announce ... of Pharma To Market Pte Ltd, based in Singapore ... their expansion into Asia with the opening ... are delighted to appoint Joelle Chia , former owner of ... based entity. Joelle brings with her an extensive business network throughout ...
(Date:2/24/2017)...  The particle counters market is projected to ... 275.9 million in 2016, at a CAGR of ... http://www.reportlinker.com/p04718602-summary/view-report.html The growing pharmaceutical and ... growth in manufacturing industries in emerging nations are ... counters. On the other hand, technical limitations of ...
(Date:2/24/2017)... Research and Markets has announced the addition of the "Urinary ... their offering. ... The latest research Urinary Incontinence Drugs Price Analysis and Strategies - ... Incontinence market. The research answers the following questions: ... Incontinence and their clinical attributes? How are they positioned in the ...
Breaking Medicine Technology: